Bloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trials for AstraZeneca's COVID-19 vaccine
Bloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trials for AstraZeneca's COVID-19 vaccine.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
NewsBloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trials for AstraZeneca's COVID-19 vaccine
View Premium plansBrowse free archive reportsBloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trials for AstraZeneca's COVID-19 vaccine.